TABLE 3.
Relationship between dietary nutritional intake and sleep disorders in hypertensive patients.
| Exposure | Model 1 [OR (95% CI)] | P-value | Model 2 [OR (95% CI)] | P-value | Model 3 [OR (95% CI)] | P-value |
| Total sugars/100 | 1.16 (1.10, 1.22) | < 0.0001*** | 1.16 (1.10, 1.23) | < 0.0001*** | 1.19 (1.13, 1.26) | < 0.0001*** |
| Dietary fiber/100 | 0.39 (0.27, 0.58) | < 0.0001*** | 0.61 (0.41, 0.92) | 0.0172 | 0.93 (0.61, 1.41) | 0.7355 |
| Total fat/100 | 1.17 (1.07, 1.27) | 0.0004** | 1.25 (1.14, 1.37) | < 0.0001*** | 1.21 (1.10, 1.33) | < 0.0001*** |
| Retinol/100 | 1.01 (1.00, 1.01) | 0.0599 | 1.01 (1.00, 1.01) | 0.0887 | 1.01 (1.00, 1.01) | 0.0941 |
| Alpha-carotene/100 | 1.00 (0.99, 1.00) | 0.2539 | 1.00 (0.99, 1.00) | 0.3490 | 1.00 (1.00, 1.00) | 0.7827 |
| Beta-carotene/100 | 1.00 (1.00, 1.00) | 0.0028** | 1.00 (1.00, 1.00) | 0.0066** | 1.00 (1.00, 1.00) | 0.1769 |
| Lycopene/100 | 1.00 (1.00, 1.00) | 0.4511 | 1.00 (1.00, 1.00) | 0.5726 | 1.00 (1.00, 1.00) | 0.8744 |
| Vitamin B6/100 | 0.33 (0.02, 4.53) | 0.4073 | 1.74 (0.12, 25.15) | 0.6826 | 5.62 (0.37, 85.26) | 0.2130 |
| Vitamin C/100 | 0.94 (0.90, 0.98) | 0.0074** | 0.96 (0.92, 1.01) | 0.0999 | 1.00 (0.95, 1.05) | 0.9703 |
| Calcium/100 | 1.02 (1.01, 1.02) | < 0.0001*** | 1.02 (1.01, 1.02) | < 0.0001*** | 1.02 (1.01, 1.03) | < 0.0001*** |
| Copper/100 | 0.02 (0.00, 1.28) | 0.0654 | 0.16 (0.00, 9.18) | 0.3734 | 1.03 (0.02, 59.05) | 0.9884 |
| Potassium/100 | 1.00 (1.00, 1.00) | 0.3062 | 1.00 (1.00, 1.00) | 0.5255 | 1.00 (1.00, 1.01) | 0.0466* |
| Total sugars (quartile) | ||||||
| Quartile 1 | Reference | Reference | Reference | |||
| Quartile 2 | 0.98 (0.89, 1.07) | 0.6441 | 0.97 (0.88, 1.06) | 0.4601 | 0.99 (0.90, 1.08) | 0.7654 |
| Quartile 3 | 1.05 (0.96, 1.15) | 0.2820 | 1.04 (0.95, 1.14) | 0.4408 | 1.09 (0.99, 1.20) | 0.0636 |
| Quartile 4 | 1.17 (1.07, 1.28) | 0.0008** | 1.16 (1.06, 1.28) | 0.0017** | 1.23 (1.11, 1.35) | < 0.0001*** |
| P for trend | 1.15 (1.07, 1.24) | < 0.0001*** | 1.15 (1.07, 1.24) | 0.0002*** | 1.20 (1.12, 1.30) | < 0.0001*** |
| Total fat (quartile) | ||||||
| Quartile 1 | Reference | Reference | Reference | |||
| Quartile 2 | 1.03 (0.94, 1.13) | 0.4672 | 1.02 (0.93, 1.12) | 0.6197 | 1.03 (0.93, 1.13) | 0.5778 |
| Quartile 3 | 0.99 (0.91, 1.09) | 0.8935 | 1.00 (0.91, 1.09) | 0.9413 | 0.99 (0.90, 1.09) | 0.7786 |
| Quartile 4 | 1.13 (1.03, 1.24) | 0.0081** | 1.19 (1.08, 1.31) | 0.0003*** | 1.17 (1.06, 1.29) | 0.0019** |
| P for trend | 1.15 (1.03, 1.28) | 0.0124* | 1.23 (1.10, 1.38) | 0.0004*** | 1.20 (1.07, 1.35) | 0.0025** |
| Calcium (quartile) | ||||||
| Quartile 1 | Reference | Reference | Reference | |||
| Quartile 2 | 1.00 (0.92, 1.10) | 0.9330 | 0.99 (0.90, 1.09) | 0.8135 | 1.00 (0.91, 1.10) | 0.9767 |
| Quartile 3 | 1.05 (0.96, 1.15) | 0.2642 | 1.04 (0.95, 1.14) | 0.3742 | 1.06 (0.97, 1.17) | 0.2141 |
| Quartile 4 | 1.13 (1.03, 1.24) | 0.0087** | 1.14 (1.04, 1.25) | 0.0073** | 1.18 (1.07, 1.30) | 0.0010** |
| P for trend | 1.01 (1.00, 1.02) | 0.0036** | 1.02 (1.01, 1.02) | 0.0024** | 1.02 (1.01, 1.02) | 0.0003** |
Model 1, no covariates were adjusted; Model 2, age, gender, and race were adjusted; Model 3, gender, age, race, Education level, Marital status; PIR; BMI; Total cholesterol; Alcohol consumption; smoking; Diabetes; Coronary heart disease and stroke were adjusted. 95% CI, 95% confidence interval; OR, odds ratio; *p < 0.05, **p < 0.01, ***p < 0.001; ap < 0.05 was considered statistically significant. Significant values are in bold.